Actorise 25 Injection
Marketer
Cipla Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Actorise 25 Injection
Epoetin alfa 25mcg Injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. This medication requires careful administration due to potential serious adverse effects; expert medical supervision is crucial. Strict adherence to your doctor's instructions is essential, as administration occurs under professional healthcare guidance. Possible side effects include hypertension and hypersensitivity reactions. Report symptoms of severe hypertension—such as intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests will monitor electrolyte (potassium) levels, hemoglobin, and blood cell counts. Discontinue use and consult your physician if shortness of breath or a skin rash develops. A patient assistance program, facilitated by Tata 1mg, is available in India. Inquire with your doctor or call (1800-102-1618) for program details.
Uses of Actorise 25 Injection
Managing anemia in patients with chronic kidney disease | Addressing chemotherapy-induced anemia
Major Benefits of Actorise 25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Actorise 25 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Actorise 25 Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Actorise 25 Injection works:
Actorise 25 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting the bone marrow to increase its output of red blood cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Actorise 25 Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Actorise 25 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Actorise 25 Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Actorise 25 Injection.
KidneySAFE IF PRESCRIBED
Actorise 25 Injection poses no safety concerns for individuals with kidney impairment; no alteration of the prescribed dosage is necessary.
LiverCAUTION
Patients with hepatic impairment should use Actorise 25 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Actorise 25 Injection :
Should you forget a dose of Actorise 25 Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Actorise 25 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Erythropoietin-stimulating medication |
3,018 People bought this recently